127 related articles for article (PubMed ID: 27389087)
1. SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer.
Wang Q; Yang ZL; Zou Q; Yuan Y; Li J; Liang L; Zeng G; Chen S
Cancer Invest; 2016 Jul; 34(6):255-64. PubMed ID: 27389087
[TBL] [Abstract][Full Text] [Related]
2. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.
Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z
World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944
[TBL] [Abstract][Full Text] [Related]
3. N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas.
Yi S; Yang ZL; Miao X; Zou Q; Li J; Liang L; Zeng G; Chen S
Pathol Res Pract; 2014 Jun; 210(6):363-8. PubMed ID: 24636838
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
Yuan Y; Yang ZL; Zou Q; Li JH; Li DQ; Liang LF; Zeng GX; Chen SL
Neoplasma; 2013; 60(6):698-705. PubMed ID: 23906305
[TBL] [Abstract][Full Text] [Related]
5. Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
Miao X; Yang ZL; Xiong L; Zou Q; Yuan Y; Li J; Liang L; Chen M; Chen S
Int J Clin Exp Pathol; 2013; 6(2):179-90. PubMed ID: 23330003
[TBL] [Abstract][Full Text] [Related]
6. ACE2 and FZD1 are prognosis markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of gallbladder.
Li J; Yang ZL; Ren X; Zou Q; Yuan Y; Liang L; Chen M; Chen S
J Mol Histol; 2014 Feb; 45(1):47-57. PubMed ID: 23921915
[TBL] [Abstract][Full Text] [Related]
7. MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder.
Liu Z; Yang Z; Jiang S; Zou Q; Yuan Y; Li J; Li D; Liang L; Chen M; Chen S
Mol Med Rep; 2016 Nov; 14(5):4581-4592. PubMed ID: 27748889
[TBL] [Abstract][Full Text] [Related]
8. The Expression of Notch 1 and Notch 3 in Gallbladder Cancer and Their Clinicopathological Significance.
Liu L; Yang ZL; Wang C; Miao X; Liu Z; Li D; Zou Q; Li J; Liang L; Zeng G; Chen S
Pathol Oncol Res; 2016 Jul; 22(3):483-92. PubMed ID: 26634853
[TBL] [Abstract][Full Text] [Related]
9. CFL1 and Arp3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinomas of gallbladder.
Yang ZL; Miao X; Xiong L; Zou Q; Yuan Y; Li J; Liang L; Chen M; Chen S
Cancer Invest; 2013 Feb; 31(2):132-9. PubMed ID: 23320827
[TBL] [Abstract][Full Text] [Related]
10. Paxillin and carbonic anhydrase IX are prognostic markers in gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.
Liu Z; Yang Z; Jiang S; Zou Q; Yuan Y; Li J; Li D; Liang L; Chen M; Chen S
Histopathology; 2014 Jun; 64(7):921-34. PubMed ID: 24354963
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of syndecan-1 and syndecan-2 expression in gallbladder squamous cell/adenosquamous carcinoma and adenocarcinoma].
Tan XG; Yang ZL; Miao XY; Liu ZR; Li DQ; Zou Q; Li JH; Liang LF
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):28-34. PubMed ID: 29365414
[No Abstract] [Full Text] [Related]
12. Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Hu Q; Shen S; Li J; Liu L; Liu X; Zhang Y; Zhou Y; Zhu W; Yu Y; Cui G
Dis Markers; 2020; 2020():3231273. PubMed ID: 32733617
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma.
Zou Q; Yang ZL; Yuan Y; Li JH; Liang LF; Zeng GX; Chen SL
World J Surg Oncol; 2013 Jun; 11():143. PubMed ID: 23782473
[TBL] [Abstract][Full Text] [Related]
14. L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma.
Choi SY; Jo YS; Huang SM; Liang ZL; Min JK; Hong HJ; Kim JM
Hum Pathol; 2011 Oct; 42(10):1476-83. PubMed ID: 21496863
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathological significance of Jagged1 and DLL4 in gallbladder cancer.
Luo Y; Yang ZL; Wang C; Miao X; Liu Z; Li D; Zou Q; Li J; Liang L; Zeng G; Chen S
Tumori; 2017 Nov; 103(6):557-565. PubMed ID: 27174628
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma.
Liu DC; Yang ZL
Pathol Res Pract; 2011 Aug; 207(8):472-8. PubMed ID: 21719208
[TBL] [Abstract][Full Text] [Related]
17. ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer.
Sun J; Yang ZL; Miao X; Zou Q; Li J; Liang L; Zeng G; Chen S
J Mol Histol; 2015 Feb; 46(1):57-65. PubMed ID: 25311765
[TBL] [Abstract][Full Text] [Related]
18. DDR2 and IFITM1 Are Prognostic Markers in Gallbladder Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas.
Li D; Yang Z; Liu Z; Zou Q; Yuan Y
Pathol Oncol Res; 2019 Jan; 25(1):157-167. PubMed ID: 29043607
[TBL] [Abstract][Full Text] [Related]
19. Squamous cell/adenosquamous carcinomas and adenocarcinomas of the gallbladder: an immunohistochemistry study of prognostic markers.
Li J; Yang ZL; Zou Q; Yuan Y; Li J; Liang L; Zhen G; Chen S
Pathol Oncol Res; 2014 Apr; 20(2):285-92. PubMed ID: 24078426
[TBL] [Abstract][Full Text] [Related]
20. Expression of SHP2 and related markers in non-small cell lung cancer: a tissue microarray study of 80 cases.
Tang C; Luo D; Yang H; Wang Q; Zhang R; Liu G; Zhou X
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):386-94. PubMed ID: 23343958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
